Select for export 19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations No abstract availability was recorded for this entry. Details DOI 10.1016/j.jaac.2022.07.664 Copy citation Copy BibTeX Journal of the American Academy of Child & Adolescent Psychiatry 2022-09-30 Natalie Gukasyan OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Randomized Controlled Trial More
Select for export New investigational agents for the treatment of major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/13543784.2022.2113376 PubMed 35975761 Copy citation Copy BibTeX Expert opinion on investigational drugs 2022-09-30 Pochwat B, Krupa AJ, Siwek M, Szewczyk B PubMed Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Review Article More
Select for export Effects of psilocybin versus escitalopram on rumination and thought suppression in depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjo.2022.565 PubMed 36065128 Copy citation Copy BibTeX BJPsych Open 2022-09-05 Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop Abstract available at the source but not redistributed here. Read at source. Details PubMed 36049038 Copy citation Copy BibTeX National Academies Press (US), Washington (DC) 2022-08-31 National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
Select for export The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.29167 PubMed 36259015 Copy citation Copy BibTeX Cureus 2022-08-31 Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N PubMed Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/17460441.2022.2111415 PubMed 35934973 Copy citation Copy BibTeX Expert Opinion on Drug Discovery 2022-08-21 Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM. Europe PMC Published psilocybin DepressionPharmacologyMechanism of Action Animal Study More
Select for export The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/07067437221111371 PubMed 35975555 Copy citation Copy BibTeX Unknown journal 2022-08-16 Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11920-022-01361-0 PubMed 35953638 Copy citation Copy BibTeX Unknown journal 2022-08-11 Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. Europe PMC Published psilocybin DepressionEnd-of-Life DistressMechanism of Action Clinical Trial More
Select for export The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06187-5 PubMed 35939083 Copy citation Copy BibTeX Psychopharmacology 2022-08-07 Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L Europe PMC Published psilocybin DepressionEmotional ProcessingClinical Trial Randomized Controlled Trial More
Select for export Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.06.29.498015 Copy citation Copy BibTeX bioRxiv 2022-07-02 Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL. bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionNeuroplasticityMechanism of Action Other More
Select for export A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/sb5ur Copy citation Copy BibTeX PsyArXiv 2022-06-30 Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas F, Peill JM PsyArXiv PREPRINT (not peer reviewed) psilocybin Depression Other More
Select for export Self-administration of Psilocybin in the Setting of Treatment-resistant Depression. Abstract available at the source but not redistributed here. Read at source. Details PubMed 36204170 Copy citation Copy BibTeX PubMed 2022-06-30 Lyons A. Europe PMC Published psilocybin DepressionMicrodosingRandomized Controlled Trial Clinical Trial More
Select for export A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2022-06-30 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin Depression Other More
Select for export Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls No abstract availability was recorded for this entry. Details DOI 10.25316/ir-20556 Copy citation Copy BibTeX VIUspace 2022-06-29 Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault OpenAlex Published psilocybin DepressionMicrodosingObservational Study Observational Study More
Select for export Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2022.927984 PubMed 35837277 Copy citation Copy BibTeX Unknown journal 2022-06-27 Vorobyeva N, Kozlova AA. Europe PMC Published psilocybin DepressionAnxietyPTSD Review Article More
Select for export 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.26402 PubMed 35915689 Copy citation Copy BibTeX Unknown journal 2022-06-27 Inouye A, Wolfgang A. Europe PMC Published psilocybin DepressionPTSDClinical Trial Clinical Trial More
Select for export Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2022.00211 Copy citation Copy BibTeX Journal of Psychedelic Studies 2022-06-08 Annie M. McCartney, H. T. McGovern, Alexander De Foe OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1200/jco.2022.40.16_suppl.12097 Copy citation Copy BibTeX Journal of Clinical Oncology 2022-05-31 Manish Agrawal, Paul Thambi, Sarah Shnayder OpenAlex Published psilocybin DepressionAnxietyClinical Trial Clinical Trial More
Select for export How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06106-8 PubMed 35348806 Copy citation Copy BibTeX Psychopharmacology 2022-05-31 van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH PubMed Published psilocybin DepressionPharmacologyMystical Experience Other More
Select for export Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits? No abstract availability was recorded for this entry. Details DOI 10.1080/14740338.2022.2063274 PubMed 35387542 Copy citation Copy BibTeX Expert opinion on drug safety 2022-05-31 Husain MI, Umer M, Mulsant BH PubMed Published psilocybin DepressionPTSDAddiction Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.